These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19288018)

  • 1. Pathogenetic mechanisms and treatment options for ophthalmic pterygium: trends and perspectives (Review).
    Detorakis ET; Spandidos DA
    Int J Mol Med; 2009 Apr; 23(4):439-47. PubMed ID: 19288018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic alterations and viral presence in ophthalmic pterygium.
    Detorakis ET; Drakonaki EE; Spandidos DA
    Int J Mol Med; 2000 Jul; 6(1):35-41. PubMed ID: 10851263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity and p53 expression in Pterygium.
    Reisman D; McFadden JW; Lu G
    Cancer Lett; 2004 Mar; 206(1):77-83. PubMed ID: 15019163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral involvement in the pathogenesis and clinical features of ophthalmic pterygium (Review).
    Chalkia AK; Spandidos DA; Detorakis ET
    Int J Mol Med; 2013 Sep; 32(3):539-43. PubMed ID: 23856952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of vascular endothelial growth factor (VEGF) and p53 expression in pterygium from Tunisian patients.
    Khalfaoui T; Mkannez G; Colin D; Imen A; Zbiba W; Errais K; Anane R; Beltaief O; Zhioua R; Ben Hamida J; Lizard G; Ouertani-Meddeb A
    Pathol Biol (Paris); 2011 Jun; 59(3):137-41. PubMed ID: 19481369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53 protein in pterygium.
    Onur C; Orhan D; Orhan M; Dizbay Sak S; Tulunay O; Irkeç M
    Eur J Ophthalmol; 1998; 8(3):157-61. PubMed ID: 9793769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine.
    Perra MT; Maxia C; Corbu A; Minerba L; Demurtas P; Colombari R; Murtas D; Bravo S; Piras F; Sirigu P
    Mol Vis; 2006 Sep; 12():1136-42. PubMed ID: 17093398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and biomarker candidates in pterygium development.
    Wanzeler ACV; Barbosa IAF; Duarte B; Borges D; Barbosa EB; Kamiji D; Huarachi DRG; Melo MB; Alves M
    Arq Bras Oftalmol; 2019; 82(6):528-536. PubMed ID: 31576927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in the pathogenesis of pterygium.
    Liu T; Liu Y; Xie L; He X; Bai J
    Curr Eye Res; 2013 Dec; 38(12):1191-7. PubMed ID: 24047084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia.
    Detorakis ET; Zafiropoulos A; Arvanitis DA; Spandidos DA
    Eye (Lond); 2005 Feb; 19(2):210-4. PubMed ID: 15232598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic alterations and transformations in development and establishment of uterine endometrial carcinomas].
    Inoue M
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):751-62. PubMed ID: 8371006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pterygium: etiology, pathogenesis, treatment].
    Malozhen SA; Trufanov SV; Krakhmaleva DA
    Vestn Oftalmol; 2017; 133(5):76-83. PubMed ID: 29165417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association between BPDE-like DNA adduct levels and P53 gene mutation in pterygium.
    Lai TJ; Tsai YY; Cheng YW; Chiang CC; Lee H; Chou MC; Chang JH
    Mol Vis; 2006 Dec; 12():1687-91. PubMed ID: 17213797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability and loss of heterozygosity in human pterygia.
    Spandidos DA; Sourvinos G; Kiaris H; Tsamparlakis J
    Br J Ophthalmol; 1997 Jun; 81(6):493-6. PubMed ID: 9274415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K-ras oncogene mutation in pterygium.
    Ozturk BT; Yıldırım MS; Zamani A; Bozkurt B
    Eye (Lond); 2017 Mar; 31(3):491-498. PubMed ID: 27834959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Evolving Story of Pterygium.
    Young AL; Cao D; Chu WK; Ng TK; Yip YWY; Jhanji V; Pang CP
    Cornea; 2018 Nov; 37 Suppl 1():S55-S57. PubMed ID: 30216333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome Analysis of Pterygium and Pinguecula Reveals Evidence of Genomic Instability Associated with Chronic Inflammation.
    Suarez MF; Echenique J; López JM; Medina E; Irós M; Serra HM; Fini ME
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis of pterygium: current concepts and their therapeutic implications.
    Chui J; Di Girolamo N; Wakefield D; Coroneo MT
    Ocul Surf; 2008 Jan; 6(1):24-43. PubMed ID: 18264653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of vascular endothelial growth factor from a human melanoma cell line, WM35, is induced by hypoxia but not ultraviolet radiation and is potentiated by activated Ras mutation.
    Shellman YG; Park YL; Marr DG; Casper K; Xu Y; Fujita M; Swerlick R; Norris DA
    J Invest Dermatol; 2003 Oct; 121(4):910-7. PubMed ID: 14632212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium.
    Tsai YY; Cheng YW; Lee H; Tsai FJ; Tseng SH; Chang KC
    Mol Vis; 2005 Jan; 11():50-5. PubMed ID: 15682042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.